29.33
-0.44
(-1.48%)
1.7M
XNAS Volume
XNAS 18 Jun, 2025 5:30 PM (EDT)
Analyst Upgrade
UBS upgrades Alkermes to 'Buy'; cites confidence in the company’s orexin receptor drug
See details
